First-in-Human Single Ascending Dose of GLPG0492

NCT01130818 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: GLPG0492
DRUG: placebo
DRUG: GLPG0492
DRUG: GLPG0492

Sponsor

Lakefront Biotherapeutics NV